Straits Research released its highly anticipated report,“ Global DNA-encoded Library Market Size & Outlook, 2026-2034”. According to the study, the market size is valued at USD 851.06 million in 2025 ...
Nurix advances CLL therapy with NX-5948 showing 83% response, 22.1-month PFS, $680M cash, and $3B risk-adjusted sales ...
Financing led by institutional investors, with participation from new investor Eli Lilly and CompanyInclusive of this ...
Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for ...
Phase 1 study of REX-8756 is well underway following FDA clearance of the Investigational New Drug (IND) application in December 2025--In ...
AM PSTElizabethan D - Private Company Track; Westin St. Francis Hotel, San Francisco, CAEMERYVILLE, Calif., Jan.
Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for ...
RBC Ukraine on MSN
'If Antarctica melts, cities will go underwater'. Ukrainian polar scientist on working at the edge of the world
How Ukrainian polar researchers live and work in Antarctica, what threats emerge at the “edge” of the world, what is ...
By year-end 2028, submit new drug application evaluating cemsidomide and dexamethasone for potential accelerated approval in fourth line or later. In Q2 2026, initiate the Phase 1b trial of ...
Gene-editing technologies show great promise for medical treatments and research, with the potential to cure thousands of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback